Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Jerlo Company has recently confirmed that the net product revenue of its drug Rytelo is expected to remain in the range of 220 to 240 million US dollars for the 2026 fiscal year.

Jerlo Company has recently confirmed that the net product revenue of its drug Rytelo is expected to remain in the range of 220 to 240 million US dollars for the 2026 fiscal year.

老虎证券老虎证券2026/05/06 11:09
Show original
This expected range is consistent with the company's previously announced financial guidance, highlighting management's confidence in the market performance of this product.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The Fed votes to approve stress test reforms, with Wall Street banks achieving a sweeping victory.

The Federal Reserve on Wednesday voted to approve the final rules for its annual stress tests, marking a major victory for large Wall Street banks.

智通财经•2026/09/30 13:46
The Fed votes to approve stress test reforms, with Wall Street banks achieving a sweeping victory.